vs
Side-by-side financial comparison of AMERISAFE INC (AMSF) and EXPONENT INC (EXPO). Click either name above to swap in a different company.
EXPONENT INC is the larger business by last-quarter revenue ($166.3M vs $80.1M, roughly 2.1× AMERISAFE INC). EXPONENT INC runs the higher net margin — 17.8% vs 10.2%, a 7.6% gap on every dollar of revenue. On growth, EXPONENT INC posted the faster year-over-year revenue change (14.3% vs 10.3%). Over the past eight quarters, EXPONENT INC's revenue compounded faster (8.8% CAGR vs 2.8%).
AMERISAFE Inc. is a specialty insurance provider that focuses exclusively on workers' compensation coverage for small and mid-sized businesses in high-hazard industries including construction, logging, trucking, and manufacturing. It operates across 49 U.S. states, offering tailored insurance policies paired with targeted risk management support for clients.
Exponent, Inc. is an American engineering and scientific consulting firm. Exponent has a team of scientists, physicians, engineers, and business consultants which performs research and analysis in more than 90 technical disciplines. The company operates 20 offices in the United States and five offices overseas.
AMSF vs EXPO — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2027
| Metric | | |
|---|---|---|
| Revenue | $80.1M | $166.3M |
| Net Profit | $8.1M | $29.6M |
| Gross Margin | — | — |
| Operating Margin | — | 24.9% |
| Net Margin | 10.2% | 17.8% |
| Revenue YoY | 10.3% | 14.3% |
| Net Profit YoY | -9.0% | 11.0% |
| EPS (diluted) | $0.43 | $0.59 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $80.1M | $166.3M | ||
| Q4 25 | $81.6M | $147.1M | ||
| Q3 25 | $82.0M | $142.0M | ||
| Q2 25 | $81.1M | $145.5M | ||
| Q1 25 | $72.6M | $136.8M | ||
| Q4 24 | $74.0M | — | ||
| Q3 24 | $78.7M | $136.3M | ||
| Q2 24 | $75.8M | $140.5M |
| Q1 26 | $8.1M | $29.6M | ||
| Q4 25 | $10.4M | $28.0M | ||
| Q3 25 | $13.8M | $26.6M | ||
| Q2 25 | $14.0M | $26.6M | ||
| Q1 25 | $8.9M | $23.6M | ||
| Q4 24 | $13.2M | — | ||
| Q3 24 | $14.3M | $26.0M | ||
| Q2 24 | $11.0M | $29.2M |
| Q1 26 | — | 24.9% | ||
| Q4 25 | 15.6% | 19.7% | ||
| Q3 25 | 21.3% | 12.1% | ||
| Q2 25 | 21.5% | 30.5% | ||
| Q1 25 | 15.5% | 19.9% | ||
| Q4 24 | 22.7% | — | ||
| Q3 24 | 22.6% | 19.0% | ||
| Q2 24 | 18.1% | 25.4% |
| Q1 26 | 10.2% | 17.8% | ||
| Q4 25 | 12.8% | 19.1% | ||
| Q3 25 | 16.9% | 18.7% | ||
| Q2 25 | 17.2% | 18.3% | ||
| Q1 25 | 12.3% | 17.2% | ||
| Q4 24 | 17.8% | — | ||
| Q3 24 | 18.2% | 19.1% | ||
| Q2 24 | 14.5% | 20.8% |
| Q1 26 | $0.43 | $0.59 | ||
| Q4 25 | $0.55 | $0.55 | ||
| Q3 25 | $0.72 | $0.52 | ||
| Q2 25 | $0.73 | $0.52 | ||
| Q1 25 | $0.47 | $0.45 | ||
| Q4 24 | $0.69 | — | ||
| Q3 24 | $0.75 | $0.50 | ||
| Q2 24 | $0.57 | $0.57 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $34.2M | $118.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $246.6M | $338.3M |
| Total Assets | — | $687.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $34.2M | $118.6M | ||
| Q4 25 | $61.9M | $207.4M | ||
| Q3 25 | $54.7M | $231.8M | ||
| Q2 25 | $48.5M | $245.1M | ||
| Q1 25 | $44.8M | $258.9M | ||
| Q4 24 | $44.1M | — | ||
| Q3 24 | $63.7M | $219.7M | ||
| Q2 24 | $30.6M | $203.3M |
| Q1 26 | $246.6M | $338.3M | ||
| Q4 25 | $251.6M | $402.9M | ||
| Q3 25 | $274.8M | $427.8M | ||
| Q2 25 | $265.6M | $441.4M | ||
| Q1 25 | $260.8M | $421.1M | ||
| Q4 24 | $257.3M | — | ||
| Q3 24 | $314.4M | $410.3M | ||
| Q2 24 | $301.0M | $393.2M |
| Q1 26 | — | $687.4M | ||
| Q4 25 | $1.1B | $761.4M | ||
| Q3 25 | $1.2B | $759.4M | ||
| Q2 25 | $1.2B | $763.2M | ||
| Q1 25 | $1.2B | $777.3M | ||
| Q4 24 | $1.2B | — | ||
| Q3 24 | $1.3B | $744.1M | ||
| Q2 24 | $1.2B | $709.2M |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AMSF
Segment breakdown not available.
EXPO
| Revenues before reimbursements | $151.8M | 91% |
| Reimbursements | $14.5M | 9% |
